Point72 Asset Management, L.P. 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:32 pm Purchase |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Point72 Asset Management, L.P. | 472,864 2.200% |
46,702 (+10.96%) |
Filing |
| 2021-02-16 3:09 pm Purchase |
2020-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Point72 Asset Management, L.P. | 426,162 10.900% |
426,162 (New Position) |
Filing |